Cited by 806Muscle Physiology and DisordersTGF-β signaling in diseasesMuscle metabolism and nutrition

Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size

Trendelenburg, Anne Ulrike, Meyer, Angelika, Rohner, Daisy, Boyle, Joseph, Hatakeyama, Shinji, Glass, David J.·2009·American Journal of Physiology-Cell Physiology

Abstract

Myostatin is a negative regulator of skeletal muscle size, previously shown to inhibit muscle cell differentiation. Myostatin requires both Smad2 and Smad3 downstream of the activin receptor II (ActRII)/activin receptor-like kinase (ALK) receptor complex. Other transforming growth factor-beta (TGF-beta)-like molecules can also block differentiation, including TGF-beta(1), growth differentiation factor 11 (GDF-11), activins, bone morphogenetic protein 2 (BMP-2) and BMP-7. Myostatin inhibits activation of the Akt/mammalian target of rapamycin (mTOR)/p70S6 protein synthesis pathway, which mediates both differentiation in myoblasts and hypertrophy in myotubes. Blockade of the Akt/mTOR pathway, using small interfering RNA to regulatory-associated protein of mTOR (RAPTOR), a component of TOR signaling complex 1 (TORC1), increases myostatin-induced phosphorylation of Smad2, establishing a myostatin signaling-amplification role for blockade of Akt. Blockade of RAPTOR also facilitates myostatin's inhibition of muscle differentiation. Inhibition of TORC2, via rapamycin-insensitive companion of mTOR (RICTOR), is sufficient to inhibit differentiation on its own. Furthermore, myostatin decreases the diameter of postdifferentiated myotubes. However, rather than causing upregulation of the E3 ubiquitin ligases muscle RING-finger 1 (MuRF1) and muscle atrophy F-box (MAFbx), previously shown to mediate skeletal muscle atrophy, myostatin decreases expression of these atrophy markers in differentiated myotubes, as well as other genes normally upregulated during differentiation. These findings demonstrate that myostatin signaling acts by blocking genes induced during differentiation, even in a myotube, as opposed to activating the distinct "atrophy program." In vivo, inhibition of myostatin increases muscle creatine kinase activity, coincident with an increase in muscle size, demonstrating that this in vitro differentiation measure is also upregulated in vivo.

Integrity signals

Registry

Crossref · 10.1152/ajpcell.00105.2009

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 54 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Trendelenburg, A. U., Meyer, A., Rohner, D., Boyle, J., Hatakeyama, S., & Glass, D. J.
Affiliations
Novartis (Switzerland) (CH)
Venue
American Journal of Physiology-Cell Physiology
Published
2009-06
Volume
296
Issue
6
Pages
C1258-C1270
ISSN
  • 0363-6143 (ISSN-L)
  • 1522-1563
OpenAlex
W2033924360
Cited by
792
References
54
Citations by year
2026: 31 · 2025: 38 · 2024: 28 · 2023: 43 · 2022: 38 · 2021: 65 · 2020: 61 · 2019: 48 · 2018: 49 · 2017: 47 · 2016: 39 · 2015: 46 · 2014: 55 · 2013: 69 · 2012: 52
FWCI
18.14
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Physiology-Cell Physiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Muscle metabolism and nutrition
Keywords
myostatin, myogenesis, Akt/mTOR signaling, TORC1, TORC2, p70S6K, raptors, Rictor, Smad2, Smad3, activin receptors, muscle hypertrophy, muscle atrophy, MuRF1, atrogin-1, creatine kinase, skeletal muscle size
MeSH terms
Tripartite Motif Proteins, Regulatory-Associated Protein of mTOR, Rapamycin-Insensitive Companion of mTOR Protein, Animals, Benzamides, Carrier Proteins, Cell Differentiation, Cells, Cultured, Creatine Kinase, Dioxoles, Humans, Insulin-Like Growth Factor I, Muscle Proteins, Organ Size, Phosphorylation, Protein Kinases, Proteins, Transfection, Signal Transduction, Mice, SCID, Muscle Fibers, Skeletal, Activin Receptors, Type I, Myoblasts, Skeletal, RNA Interference, RNA, Small Interfering, Follistatin, Ribosomal Protein S6 Kinases, 70-kDa, Ubiquitin-Protein Ligases, SKP Cullin F-Box Protein Ligases, Protein Kinase Inhibitors, Cell Size, Adaptor Proteins, Signal Transducing, Proto-Oncogene Proteins c-akt, Mice, Smad2 Protein, Smad3 Protein, Myostatin, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review